The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid‐related diseases: An analysis of the national pharmacovigilance database in South Korea
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Digestive Diseases"
DOI: 10.1111/1751-2980.13075
Abstract: The objective of this case/non‐case study was to detect rebamipide‐related pulmonary adverse events (AE) compared with other drugs for acid‐related disorders based on population‐level data. read more here.
Keywords: drug reactions; pulmonary adverse; drugs acid; adverse drug ... See more keywords
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
Sign Up to like & getrecommendations! Published in 2022 at "Transfusion"
DOI: 10.1111/trf.16987
Abstract: Platelet transfusion carries risk of transfusion‐transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion‐related acute lung injury and acute respiratory distress syndrome (ARDS) occur… read more here.
Keywords: platelet; platelet components; pulmonary adverse; risk ... See more keywords